Aptar Appoints Julie Xing to its Board of Directors
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Julie Xing has joined its Board of Directors.
- AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Julie Xing has joined its Board of Directors.
- Since 2022, Julie has served as Executive Chair of the Board of Directors of Mundipharma China.
- “We are pleased to welcome Julie Xing to our Board of Directors.
- I am excited to join Aptar’s Board of Directors to build upon the Company’s more than 75-year history of developing innovative products that millions of people around the world use every day.”
George Fotiades, Chairman of Aptar’s Board of Directors, stated, “We look forward to welcoming Julie to our highly talented, diverse and multi-cultural Board of Directors.